首页 正文

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer

{{output}}
Ovarian cancer is the second leading cause of death from gynecologic malignancies worldwide. Management of platinum-resistant disease is challenging and clinical outcomes with standard chemotherapy are poor. Over the past decades, significant efforts have been... ...